Newly-diagnosed Pediatric Ph-positive B-ALL Protocol

Clinical trial NCT07152041 · RECRUITING

Trial details

NCT number: NCT07152041
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)Childhood Leukemia, Acute Lymphoblastic

Start date: 2025-03-28
Primary completion: 2029-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.